Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Google Inc (GOOG) vs GeneDx Holdings Corp (WGS) Price & Performance

Google IncTrade
GeneDx Holdings CorpTrade

Price performance (Past 24H)

Key statistics

Google Inc vs GeneDx Holdings Corp — how do they compare? Google Inc trades at $370.43 (market cap $4.52T), while GeneDx Holdings Corp trades at $62.99 (market cap $1.96B). The key difference: Google Inc is far larger — about 2306.1× GeneDx Holdings Corp's market cap, and Google Inc pays a 0.24% dividend while GeneDx Holdings Corp pays none. Which is the better fit depends on your goals.

GOOGWGS
Market Cap
$4.52T$1.96B
Volume
1,511,127
Sector
TechnologyTechnology
52-Week High
$399.06$167.51
52-Week Low
$183.77$34.51
Enterprise Value
$4.49T$1.96B
Dividend Yield
0.24%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Google Inc

Alphabet (GOOG) trades at $370.43, up 3.67% on the day, with strong bullish momentum from recent earnings beats and a consensus analyst price target of $457.50. The stock shows robust fundamentals with 2025 revenue of $402.84B, net income margin of 37.92%, and consistent cash flow growth. Technical indicators are bullish, with the current price near resistance at $374, while sentiment is positive due to Warren Buffett's recent endorsement and AI-driven growth prospects.

Outlook remains favorable with earnings growth and AI expansion as key catalysts, though regulatory risks and market volatility pose challenges. The stock offers upside potential aligned with analyst targets, supported by high institutional ownership and strong profitability metrics.

GeneDx Holdings Corp

GeneDx Holdings Corp. (WGS) trades at $65.785, up 5.37% today, but faces a bearish technical signal with the stock near resistance at $65. The company shows mixed fundamentals with strong revenue growth to $427.54M in 2025 but a net loss of -$21.02M, while analyst consensus remains bullish with a $75.40 price target. Recent news highlights multiple class-action lawsuits alleging securities fraud tied to a 49% stock decline and acquisition underperformance, creating significant investor uncertainty.

The outlook is highly conflicted: strong analyst buy ratings and recent earnings beats contrast with deepening losses, negative cash flow projections for 2026, and legal overhangs. Key risks include litigation outcomes, profitability challenges, and execution missteps, but the stock offers potential upside if the company can stabilize margins and resolve legal issues amid high institutional skepticism.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Google Inc

Alphabet Inc. operates as a holding company. The Company, through its subsidiaries, provides web-based search, advertisements, maps, software applications, mobile operating systems, consumer content, enterprise solutions, commerce, and hardware products.

Read more on GOOG

About GeneDx Holdings Corp

GeneDx is a patient-centered health intelligence company that specializes in transforming healthcare through the application of genomics. It combines advanced technology with one of the world's largest rare disease genomic datasets to provide clinical-grade exome and genome sequencing, enabling precise and rapid diagnosis for patients with complex medical conditions.

Read more on WGS